Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Epoetin Alfa × Clear all

Phase

Phase 3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anemia 15 Neoplasms 10 Leukemia 3 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡